Bausch + Lomb gets CE mark for Luxlife intraocular lens

Bausch + Lomb has obtained CE mark approval for its Luxlife intraocular lens (IOL), paving the way for its European launch in the coming weeks. Designed to support vision at near, intermediate, and far distances, Luxlife is a non-diffractive IOL that avoids light loss, a common issue with diffractive lenses. The Lux platform uses a different optical design than the company’s Envista IOLs, some of which were recently recalled in the U.S. due to inflammatory responses linked to a vendor-supplied raw material. The CE mark was backed by a clinical trial conducted by French IOL developer Cutting Edge, showing excellent visual outcomes. Among Luxlife recipients, 89.5% reported clear near vision and 95.6% clear intermediate vision without glasses. A non-toric version will be released first, followed by a toric model for astigmatism. The company also noted a soft European launch for its Envista Envy lens later this year, with a broader rollout in early 2026.

13-05-2025